Chemical Business Newsbase articles from August 2009

Chemical Business Newsbase archives from August 2009

Lanxess doubling Madurai plant capacity.
August 31, 2009... Lanxess India Pvt Ltd, a subsidiary of the Germany-based Lanxess Deutschland GmbH, plans to upgrade and double the capacity of its Madurai plant, which manufactures leather chemicals, speciality rubber and material protection products. The...

Blood-thinning drug could transform stroke treatment.
August 31, 2009... A new blood-thinning drug could end the use of rat poison as a primary medical treatment to prevent stroke, it was claimed on 31 Aug 2009. For half a century, thousands of patients at risk of stroke have been given warfarin to prevent blood...

New pill cuts heart attack deaths.
August 31, 2009... The drugs giant AstraZeneca has announced that its trials of a new blood thinning pill produced a 16% drop in heart attack and stoke deaths among patients. The group said the drug, Brilinta, worked better than Plavix, which is the world's second...

Daily dose of aspirin could be bad for your health.
August 31, 2009... Taking an aspirin a day to ward off heart attacks is ineffective for the "worried well" and can cause serious harm, a study has shown. The finding challenges calls for people over 50 to be prescribed aspirin as a matter of course because of its...

Breathalyser screening can detect markers for lung cancer.
August 31, 2009... Patients with suspected lung cancer could in future be breathalysed to check if they have the disease. Scientists have developed a sensor that can quickly detect lung cancer molecules on the breath. They believe the technology could lead to...

Brazil Jul 2009 industrial output up 2.2% as against Jun 2009; down 9.9% on year.
August 31, 2009... Brazil's industrial output in Jul 2009 rose for the seventh month in a row, but was significantly weaker than a year before, according to data released on 31 Aug 2009 by the Brazilian Census Bureau (IBGE). The IBGE said domestic industrial...

Oil law: Brazil's Petrobras to be operator of all subsalt blocks.
August 31, 2009... Brazil's President Luiz Inacio Lula da Silva has sent to Congress a set of bills prosing new rules for legislation governing the oil and gas sectors. In a statement, state-run oil giant Petroleo Brasileiro S/A (Petrobras) said the new regulatory...

Oil law: Brazil's Petrobras to start capitalization process.
August 31, 2009... Brazil's government will be authorized to buy additional shares in state-run oil giant Petroleo Brasileiro S/A (Petrobras), according to a new regulatory model for the oil and gas sectors, to be announced on 31 Aug 2009 in Brasilia. The move is...

Brazil's Jul 2009 pulp exports up 8.7% versus Jun 2009; -10.7% on year - Association.
August 31, 2009... Brazil's pulp exports totalled 825,000 tonnes in Jul 2009, according to preliminary figures out on 31 Aug 2009 from the Brazilian Pulp and Paper Association. This corresponds to an 8.7% increase on Jun 2009 and a 10.7% drop on Jul 2008. In Jan...

Israel: company looking to floating solar plants.
August 31, 2009... Israeli company Solaris Synergy is interested in strategic partners for the global utilization of its concept for the water-supported utilization of concentrator photovoltaics (CPV). The start-up company has developed floating CPV power plants....

Serbia: development of jadarite mine planned.
August 31, 2009... Rio Tinto is to become active in Serbia. The focus of interest is the possible mining of jadarite. Subsidiary Rio Sava Exploration is already carrying out studies at deposits at two sites. The company is satisfied with results so far. A...

China: Chalco capacity recovers gradually.
August 31, 2009... Capacity at Chinese alumina maker Chalco has gradually recovered since the end of 2008. Capacity utilization reached 67% in Jun. The operating rate for galvanized aluminium was 83%. Chalco will produce 8 M tonnes of alumina in 2009.

Russia: Shell erecting lubricants plant.
August 31, 2009... Shell is to be the first international company to erect a lubricants plant in Russia. A 200 M litres/y plant will be erected in Torschok and will come onstream at the end of 2010. Russia's is the world's third-largest lubricants market. The...

Zambia: China's Zhonghui planning copper project in copper belt.
August 31, 2009... A Zambian government spokesman says Zhonghui Holdings Ltd is to erect a copper mine in Zambia's northwest province. The project will be implemented in the next 10 years and will involve investment of $3.6 bn. A copper mine and a 300,000 tonnes/y...

China continuing to subsidize raw material imports.
August 31, 2009... China will continue its programme of subsidizing interest payments on import loans for a range of raw materials, technologies, and equipment. Imports will be of especial importance in 2009 for the government's infrastructure programme. Nickel...

Moscow to be a player on the world microchip market.
August 31, 2009... Russian state company Rosnano is in talks with US company Advanced Micro Devices (AMD) over the formation of a joint venture to produce ultra-modern chips for new generation mobile phones. There is no demand for such products in Russia, but...

Hungary: falls in sales of building materials.
August 31, 2009... The declines in the Hungarian economy are also creating problems for producers of building materials. Production of building products was down a quarter in 1H 2009. But thanks to public infrastructure projects, the worst may already be over....

China: race for control of the rare-earth market.
August 31, 2009... Plans by China to impose stricter export limits for rare earths have startled governments in industrial countries and started a race for control of this small market, which is becoming more and more important for the production of eco-friendly...

Indonesia: ExxonMobil producing oil in the Cepu field again.
August 31, 2009... Mobil-Cepu has again begun producing crude oil in Indonesia's Cepu field. Production was halted there in Mar 2009. Mobil Cepu is a joint venture of ExxonMobil and Indonesian state-run oil company PT Pertamina. Production will probably be between...

Conergy sells solar park in northern Germany to investor group.
August 31, 2009... Conergy Deutschland has sold the 4.2 MW Horup solar park to a group of investors. Conergy itself will be responsible for developing and erecting the park. Some 55,818 thin-layer modules will be completed an go onto the grid by Dec 2009....

Siegfried group expects improvement in core business.
August 31, 2009... The Siegfried group had sales of SFR 121 M in 1H 2009, a fall of 24.2% on a year earlier. EBITDA before restructuring costs was SFR 13.2 M. The Actives segment had sales of SFR 90.8 M (SFR 95.1 M in 1H 2008); EBITDA was down slightly at SFR 16.4...

Burgundy in beauty case: nutricosmetics and dietary supplements.
August 31, 2009... The Bioactive-Net project is researching into applications for bioactive substances extracted from tomato, olive and grape processing residues in body care and cosmetic products as well as food supplements. Other applications may include...

BASF: Luvigel STAR.
August 31, 2009... BASF has launched Luvigel STAR, a new polyurethane-based rheology modifier for cosmetic applications. The product can be used over a wide pH range. Its structure ensures that thickeners do not react with cationic, anionic or zwitterionic...

Clariant: new Hostacerin SFO.
August 31, 2009... Clariant has launched Hostacerin SFO, a sunflower seed oil-based emulsifier for use in cream, lotion and sun care products.

Symrise: four innovative new products.
August 31, 2009... Symrise has presented four new cosmetic ingredients at In-Cosmetics 2009. There are a natural cooling agent, an ingredient that protects the skin from long-term skin damage, an anti-ageing complex and a preservative.

Wacker-Belsil RG 90 is the new silicone elastomer gel from Wacker.
August 31, 2009... Wacker has presented its new Wacker-Belsil RG 90 silicone elastomer gel at In-Cosmetics 2009. The product can be used as a binder in powder formulations. It forms a coherent elastic film which adheres easily to skin to give a silky-soft feel.

Soliance launches Whitesphere Premium.
August 31, 2009... Soliance has launched a new lightening complex at In-Cosmetics 2009. Whitesphere Premium removes age spots. It is a combination of cosmetic ingredients which use microencapsulation technology. Spherulite is delivered directly to melanocyte cells.

Sachtleben: new UV-Titan MO40 titanium dioxide product.
August 31, 2009... Sachtleben has launched UV-Titan MO40 titanium dioxide product for cosmetic applications. It an be used in suncreen and skin care emulsions. It allows formulators to avoid an undesired bluish tone in products. UV-Titan MO40 also contains silica...

The Medicines Co drug improves survival in heart patients.
August 31, 2009... The Medicines Co announced the publication of one-year results from the landmark HORIZONS-AMI Trial. The trial showed that patients who had suffered the most severe form of heart attack and received angioplasty were significantly less likely to...

Cytokinetics Inc presents Phase IIa clinical trials data relating to omecamtiv mecarbil at the European Society of Cardiology Congress 2009.
August 31, 2009... Cytokinetics Inc announced that data from two Phase IIa clinical trials evaluating omecamtiv mecarbil (formerly CK-1827452), one in stable heart failure patients and one in patients with ischemic cardiomyopathy and angina, were presented at the...

Evotec completes acquisition of controlling majority stake in Research Support International Pvt Ltd.
August 31, 2009... Evotec AG announced that the acquisition of the controlling majority stake of Research Support International Pvt Ltd (RSIPL) has been successfully completed and that RSIPL is a 70%, majority owned subsidiary of Evotec as of 31 Aug 2009. The...

Benitec Ltd fully owned RNAi patent granted in US.
August 31, 2009... Benitec Ltd provided an update on progress with the substantial Benitec intellectual property (IP) portfolio. This update is in addition to the recent update on the continuing separate Patent Reexamination of the '099 (Graham) patent in the USA....

Novo Nordisk A/S: Transaction in own shares.
August 31, 2009... Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 Dec 2003, also referred to as the Safe Harbour rules. Under the programme Novo Nordisk will...

Chemicals group Lonza sells Singapore unit to Roche.
August 31, 2009... Swiss chemicals group Lonza has signed a deal to sell a manufacturing facility in Singapore to a Roche-owned subsidiary for up to $360 M. The purchase price of the cell culture biologic manufacturing facility was $290 M while an additional $70 M...

Boehringer Ingelheim Corp's new stroke drug looks set to replace warfarin.
August 31, 2009... Boehringer Ingelheim announced data from the landmark RE-LY study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time at the European Society of...

SeraCare whittles its way from bankrupt to profits.
August 31, 2009... These days there are a lot of examples of life sciences companies that are down on their luck following the stock market swoon and attendant credit crunch. But SeraCare Life Sciences (SeraCare) is one of few that have become profitable during...

New Braasch Biotech vaccine technology provides Growth Hormone and IGF-1 treatments without the use of drugs.
August 31, 2009... Braasch Biotech LLC (Braasch) announces its lead vaccine for Obesity, Growth Hormone Deficiencies may have beneficial use for numerous IGF-1 responsive disorders such as diabetes, heart disease and Rett Syndrome based on initial pre-clinical...

First patient enrolled in CYPRESS, a dual antiplatelet therapy trial with the Cypher sirolimus-eluting Coronary Stent.
August 31, 2009... Cordis Corp announced that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a Cypher...

Promising results of drug trial could herald a replacement for popular blood thinner.
August 31, 2009... Researchers published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), taken by millions of Americans to reduce their risk of stroke....

BrainStorm Cell Therapeutics enters into agreement for clinical-grade stem cell production for ALS.
August 31, 2009... BrainStorm Cell Therapeutics Inc (BrainStorm) has entered into an agreement with Protein Production Services Ltd (PPS), a leading manufacturing contractor, in order to start Good Manufacturing Practice (cGMP) production of its stem cell...

Peplin results for the financial year ended Jun 2009.
August 31, 2009... Peplin Inc announced financial results for year ended Jun 2009, reporting a $17.7 M cash balance. Peplin will use these funds to complete Phase III clinical trials for its lead product, PEP005 (ingenol mebutate) Gel for actinic (solar) keratosis...

PsychoGenics and AstraZeneca enter agreement to identify new treatments for central nervous system disorders.
August 31, 2009... PsychoGenics Inc and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System (CNS) disorders. Under the agreement,...

New study shows abnormal lipid levels are highly common in statin-treated patients.
August 31, 2009... According to a new analysis of 22,000 patients, nearly three-quarters of patients taking statins still had at least one lipid abnormality. These results, from a study conducted by Merck & Co Inc, Whitehouse Station, NJ, USA, which operates...

Pozen announces FDA acceptance of NDA for Vimovo.
August 31, 2009... Pozen Inc announced that the US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Vimovo (enteric-coated naproxen / immediate release esomeprazole magnesium, formerly know as PN 400). Vimovo is a fixed-dose...

Diagnostic Hybrids gets FDA clearance for the detection of influenza A (H1N1)v virus.
August 31, 2009... Diagnostic Hybrids announced that the US Food and Drug Administration (FDA) has cleared an additional claim for the company's D3 Ultra DFA Respiratory Virus Identification Kit, which confirms that the assay can detect the 2009 influenza A...

Energy Transfer Partners announces completion of Texas Independence Pipeline.
August 31, 2009... Energy Transfer Partners LP (Energy Transfer) announced the completion of the 160-mile Texas Independence Pipeline. This new natural gas pipeline increases the Partnership's take away capacity in Texas by an incremental 1.1 bn cu ft/day. Energy...

Evergreen Solar and Jiawei Solar Hold ceremonial groundbreaking at Wuhan, China manufacturing plant.
August 31, 2009... In a ceremony on 31 Aug 2009 in Wuhan, China, Evergreen Solar Inc and its contract manufacturing partner, Jiawei Solarchina Co (Jiawei) celebrated the groundbreaking for their new 100 megawatt manufacturing plants. The ceremony celebrated the...

Crosstex to sell natural gas treating business for $266 M.
August 31, 2009... The Crosstex Energy companies (Crosstex), Crosstex Energy LP (the Partnership) and Crosstex Energy Inc (the Corporation), announced that the Partnership has entered into an agreement to sell the Partnership's natural gas treating business to...

Celladon Corp and Momentum Research complete enrolment of Mydicar Phase II study of first-in-human gene transfer to treat patients with advanced heart failure.
August 31, 2009... Celladon Corp and Momentum Research Inc announced completion of enrolment of the Phase II double-blind portion of the Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial. Momentum Research is...

China Green Agriculture Inc announces grand opening of new 40,000 tonne capacity production facility.
August 31, 2009... China Green Agriculture Inc (China Green) announced the opening of its newest production facility in X'ian, China. The announcement of the new facility was made in May 2008 and the facility began formal production in Aug 2009. China Green held...

United Steelworkers union calls for industry-wide phase-out of hydrogen fluoride in oil refinery alkylation units.
August 31, 2009... The United Steelworkers (USW) is calling for a phase-out of hydrogen fluoride alkylation units through the US. Hydrogen fluoride is such a deadly component, and there are new and safer technologies available. It's a matter of health and safety...

China XD Plastics to add high-end modified nylon products.
August 31, 2009... China XD Plastics Co Ltd announced that the company's wholly owned subsidiary, Harbin Xinda Macromolecule Material Co Ltd (Xinda), entered into a long-term non-exclusive agreement with Changchun Wanbofeng Plastics Co Ltd (Wanbofeng) to...

ShengdaTech Inc begins production at new NPCC facility in Zibo.
August 31, 2009... ShengdaTech Inc announced that the company's new nano-precipitated calcium carbonate (NPCC) production facility, in Zibo, Shandong Province, commenced production of their first phase of 60,000 tonnes on 28 Aug 2009. With the additional capacity...

Huntsman signs 'stalking horse' asset purchase agreement with Tronox.
August 31, 2009... Huntsman Corp has signed a 'stalking horse' asset and equity purchase agreement pursuant to which its wholly-owned subsidiary Huntsman Pigments LLC has agreed to acquire the following assets of Tronox Inc and its subsidiaries under the US...

New assessment quantifies risks and benefits of warfarin treatment for atrial fibrillation.
August 31, 2009... Warfarin (an oral anticoagulant) therapy for patients with atrial fibrillation - the most common type of significant heart rhythm disorder - appears to be most beneficial for the oldest patients, for those who have had a prior stroke and for...

Hospira receives FDA approval for six new presentations of Heparin.
August 31, 2009... Hospira Inc announced that the US Food and Drug Administration (FDA) has approved the company's applications for six new presentations of therapeutic heparin in single- and multiple-dose vials. Heparin is used to prevent clot formation in...

Cardio3 BioSciences presents update on C-Cure second generation stem cell therapy for heart failure at European Society of Cardiology Congress.
August 31, 2009... Cardio3 BioSciences provided an update and review of the clinical development of its unique C-Cure therapy at the European Society of Cardiology Congress in Barcelona. A unique second generation stem-cell derived therapy, C-Cure allows the...

Tests confirm HandClens hand sanitizer kills H1N1 flu virus.
August 31, 2009... Woodward Laboratories (Woodward Labs) announced that an independent testing laboratory has confirmed the efficacy of HandClens, an alcohol-free hand sanitizer, against H1N1 flu virus. The test results show HandClens is 99.99% effective against...

Advanced Life Sciences' restanza demonstrates efficacy in treating anthrax infection.
August 31, 2009... Advanced Life Sciences Holdings Inc (Advanced Life Sciences) announced positive results from an animal study involving its novel, once-a-day, oral antibiotic Restanza (cethromycin) that was conducted to measure Restanza's therapeutic efficacy in...

Recently published study demonstrates pharmacokinetic advantages of Endometrin over Crinone for progesterone supplementation.
August 31, 2009... Endometrin (progesterone) Vaginal Inserts, 100 mg showed clear advantages over Crinone (progesterone gel) for progesterone supplementation, according to the results of a new pharmacokinetic (PK) study. Endometrin rapidly reached higher...

Regado Biosciences releases positive Phase IIa data for the reversible anticoagulant system REG1 at the European Society of Cardiology Congress in Barcelona, Spain.
August 31, 2009... Regado Biosciences announced that the results of a Phase IIa clinical trial of their lead product, the anticoagulant system REG1, were released at the European Society of Cardiology Congress in Barcelona, Spain. The results, detailed in a poster...

Rib-X Pharmaceuticals antibiotic drug discovery platform discovers novel compounds with activity against key multiple drug resistant Gram-negative bacteria.
August 31, 2009... Rib-X Pharmaceuticals Inc (Rib-X) announced that one of its discovery-stage programmes has yielded several computationally designed series of chemically unique compounds demonstrating efficacy in the treatment of infection in animal models. The...

Sinovac's H1N1 vaccine passes experts evaluation organized by SFDA.
August 31, 2009... Sinovac Biotech Ltd (Sinovac) announced that Sinovac's H1N1 vaccine has passed the experts evaluation organized by State Food and Drug Administration (SFDA). The vaccine is expected to obtain the production licence within the last week of Aug...

IDRI to use NanoPass microneedle technology for intradermal vaccines and diagnostic skin tests.
August 31, 2009... The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd (NanoPass) have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products...

FDA grants Delcath orphan-drug designation for doxorubicin.
August 31, 2009... Delcath Systems Inc (Delcath) announced that the US Food & Drug Administration (FDA) granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver...

Nuevolution announces new research collaboration with big pharma.
August 31, 2009... Nuevolution A/S has entered into a drug discovery collaboration with Novartis. During the collaboration, Nuevolution will apply its proprietary Chemetics drug discovery technology to identify novel small molecule leads against drug targets of...

Abbott launches next-generation Xience Prime drug eluting stent in international markets.
August 31, 2009... Abbott announced at the European Society of Cardiology Congress the widespread availability of its next-generation Xience Prime Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. Xience Prime, which received...

FDA approves Valcyte (valganciclovir hydrochloride) to prevent cytomegalovirus (CMV) disease in pediatric patients who receive heart or kidney transplants.
August 31, 2009... Roche announced that the US Food and Drug Administration (FDA) has approved Valcyte (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of...

Cost effective solution for patient testing: Introducing comprehensive and affordable molecular diagnosis with verifiable accuracy.
August 31, 2009... San Diego-based MultiGEN Diagnostics Inc has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics. MultiGEN's patented platform technology allows detection and...

Catalyst Pharmaceutical Partners licenses exclusive rights to new class of GABA aminotransferase inhibitors from Northwestern University.
August 31, 2009... Catalyst Pharmaceutical Partners Inc (Catalyst Pharmaceutical) announced that the company executed a licence agreement under which it acquired exclusive worldwide rights to commercialize novel GABA aminotransferase inhibitors and derivatives of...

Crestor reduced risk of cardiovascular events in elderly patients in new analysis of JUPITER.
August 31, 2009... A new analysis from the JUPITER study showed that Crestor (rosuvastatin calcium) 20 mg reduced the composite primary end point of major cardiovascular events (myocardial infarction, stroke, arterial revascularization, hospitalization for...

Yukon-Nevada Gold Corp closes final tranche of private placement.
August 31, 2009... Yukon-Nevada Gold Corp has closed its $4.105 M non-brokered private placement for at total of 41.05 M units at a price of $0.1/unit. As reported in a previous news release dated 10 Aug 2009, the first tranche closed on 7 Aug 2009 representing...

Uranium International Corp update of option to purchase HRU licenses.
August 31, 2009... Uranium International Corp announced that the contemplated purchase of HRU licenses from Continental Precious Minerals Inc (Continental) previously announced in the company's release dated 29 Apr 2009 will not be going ahead. The company had...

LDK Solar Partners with Suqian City on PV projects.
August 31, 2009... LDK Solar Co Ltd has entered into an agreement with Suqian City of Jiangsu Province for the development of PV power projects. According to the agreement, LDK Solar will develop PV power projects in buildings, plants and integration systems,...

Roche and Lonza announce opt-in for Singapore manufacturing facility.
August 31, 2009... On 31 Aug 2009, Roche and Lonza announced that Genentech Singapore Pte Ltd, a wholly-owned member of the Roche Group, elected to exercise an option to purchase from Lonza its cell culture biologic manufacturing facility in Singapore. The...

Vivalis: Significant improvement in performance and confirmation of 2009 targets.
August 31, 2009... Vivalis announces its 1H 2009 results for the period ended Jun 2009 and strategic outlook. Operating income totalled EUR 4.9 M for 1H 2009, surging 86% over 1H 2008 largely on growth in licensing income. Licensing income and services provided by...

BioSyent Inc releases 2Q 2009 financial results.
August 31, 2009... BioSyent Inc released a summary of its 2Q 2009 financial results. During 2Q 2009 sales increased by 11%, from $236,576 in 2Q 2008 to $263,622 for 2Q 2009. Total Sales fell by 29% from $524,573 in 1H 2008 to $370,673 for 1H 2009. The 1H 2009 was...

Dow announces epoxy products price increases in Asia Pacific (excluding Japan).
August 31, 2009... Effective 1 Sep 2009, Dow Epoxy will increase the price of its liquid, solid and solid solution epoxy resins, blends, standard brominated resins and epoxy novolac resins by $100/tonne in Asia Pacific (excluding Japan).

BASF to increase prices for glues.
August 31, 2009... With effect from 1 Sep 2009 BASF is to increase the sales prices of its Kaurit and Kauramin glues by EUR 15/tonne. These price adjustments are necessary to maintain the production and to secure the reliable supply of its customers in the current...

New and generic drug approvals: Astepro Nasal Spray, Meda Pharms.
August 31, 2009... On 31 Aug 2009, the US Food and Drug Administration announced approval of NDA 022371 for Astepro Nasal Spray. The product contains azelastine hydrochloride at 0.15%, is manufactured by Meda Pharms, and is prescription only. There are no...

New and generic drug approvals: Irbesartan Oral Tablet, Cipla.
August 31, 2009... On 31 Aug 2009, the US Food and Drug Administration announced the tentative approval of ANDA 077205 for Irbesartan Oral Tablet. The product contains irbesartan at 75mg, 150mg, or 300mg and is manufactured by Cipla Ltd. There are no therapeutic...

New and generic drug approvals: Ibuprofen Oral Suspension/Drops, Tris Pharma. [1 table in original article].
August 31, 2009... On 31 Aug 2009, the US Food and Drug Administration announced approval of ANDA 079058 for Ibuprofen Oral Suspension/Drops. The product contains ibuprofen at 40mg/ml, is manufactured by Tris Pharma Inc, and is an over-the-counter (OTC) product....

New and generic drug approvals: Benztropine Mesylate Injection, Hikma Farmaceutica. [1 table in original article].
August 31, 2009... On 31 Aug 2009, the US Food and Drug Administration announced approval of ANDA 090287 for Benztropine Mesylate Injection. The product contains benztropine mesylate at 1mg/ml, is manufactured by Hikma Farmaceutica, and is prescription only. There...

New and generic drug approvals: Phentermine Hydrochloride Oral Tablet, Barr. [1 table in original article].
August 31, 2009... On 31 Aug 2009, the US Food and Drug Administration announced approval of ANDA 090470 for Phentermine Hydrochloride Oral Tablet. The product contains phentermine hydrochloride at 37.5mg, is manufactured by Barr, and is prescription only. There...